Exploring Beneficial Properties of Haskap Berry Leaf Compounds for Gut Health Enhancement
Open Access
- 17 March 2024
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 13 (3) , 357
Abstract
This study investigates the potential of formulated systems utilising haskap berry leaf extracts and dextran as carriers, to modulate both antioxidant and enzymatic inhibitory activities and their impact on the growth of specific bacterial strains. The analysis of antioxidant capacity, assessed through ABTS, CUPRAC, DPPH, and FRAP assays, revealed varying but consistently high levels across extracts, with Extract 3 (loganic acid: 2.974 mg/g, chlorogenic acid: 1.125 mg/g, caffeic acid: 0.083 mg/g, rutin: 1.137 mg/g, and quercetin: 1.501 mg/g) exhibiting the highest values (ABTS: 0.2447 mg/mL, CUPRAC: 0.3121 mg/mL, DPPH: 0.21001 mg/mL, and FRAP: 0.3411 mg/mL). Subsequent enzymatic inhibition assays demonstrated a notable inhibitory potential against α-glucosidase (1.4915 mg/mL, expressed as acarbose equivalent), hyaluronidase (0.2982 mg/mL, expressed as quercetin equivalent), and lipase (5.8715 µg/mL, expressed as orlistat equivalent). Further system development involved integration with dextran, showcasing their preserved bioactive compound content and emphasising their stability and potential bioactivity. Evaluation of the dextran systems’ impact on bacterial growth revealed a significant proliferation of beneficial strains, particularly the Bifidobacterium and lactobacilli genus (Bifidobacterium longum: 9.54 × 107 to 1.57 × 1010 CFU/mL and Ligilactobacillus salivarius: 1.36 × 109 to 1.62 × 1010 CFU/mL), suggesting their potential to modulate gut microbiota. These findings offer a foundation for exploring the therapeutic applications of haskap berry-based dextran systems in managing conditions like diabetes, emphasising the interconnected roles of antioxidant-rich botanical extracts and dextran formulations in promoting overall metabolic health.Keywords
Funding Information
- Narodowe Centrum Nauki (2020/39/O/NZ7/03441)
This publication has 81 references indexed in Scilit:
- Gut microbiota-mediated associations of green tea and catechin intakes with glucose metabolism in individuals without type 2 diabetes mellitus: a four-season observational study with mediation analysisArchives of Microbiology, 2023
- The protective effects of rutin on the liver, kidneys, and heart by counteracting organ toxicity caused by synthetic and natural compoundsFood Science & Nutrition, 2022
- Rethinking healthy eating in light of the gut microbiomeCell Host & Microbe, 2022
- The inhibitory mechanism of chlorogenic acid and its acylated derivatives on α-amylase and α-glucosidaseFood Chemistry, 2022
- Myricetin: a Multifunctional Flavonol in BiomedicineCurrent Pharmacology Reports, 2022
- Targeted Delivery of Probiotics: Perspectives on Research and CommercializationProbiotics and Antimicrobial Proteins, 2021
- Application of prebiotics in apple products and potential health benefitsJournal of Food Science and Technology, 2021
- Pharmacological screening of the phenolic compound caffeic acid using rat aorta, uterus and ileum smooth muscleChemico-Biological Interactions, 2020
- Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-ĸB pathwaysInternational Immunopharmacology, 2018
- Caffeic acid attenuates the inflammatory stress induced by glycated LDL in human endothelial cells by mechanisms involving inhibition of AGE‐receptor, oxidative, and endoplasmic reticulum stressBioFactors, 2017